Jan M. H. Van den Brande
Laboratory for Experimental Internal Medicine
G2-133
Academic Medical Center
Meibergdreef 9
Netherlands
Name/email consistency: high
- Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease. Van den Brande, J.M., Koehler, T.C., Zelinkova, Z., Bennink, R.J., te Velde, A.A., ten Cate, F.J., van Deventer, S.J., Peppelenbosch, M.P., Hommes, D.W. Gut (2007)
- Infliximab induced T lymphocyte apoptosis in Crohn's disease. van den Brande, J., Hommes, D.W., Peppelenbosch, M.P. J. Rheumatol. Suppl (2005)
- Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Van den Brande, J.M., Braat, H., van den Brink, G.R., Versteeg, H.H., Bauer, C.A., Hoedemaeker, I., van Montfrans, C., Hommes, D.W., Peppelenbosch, M.P., van Deventer, S.J. Gastroenterology (2003)